Phase I Study of Chimeric Anti-Cd20 Monoclonal Antibody in Chinese Patients With CD20-positive Non-Hodgkin’s Lymphoma
Chinese Journal of Cancer Research - Hong Kong
doi 10.21147/j.issn.1000-9604.2016.02.07
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Chinese Journal of Cancer Research